Information accurate as of February 10th, 2020
Athenahealth is actively monitoring the spread of the 2019 novel coronavirus (2019-nCoV) now global in reach having been reported in a growing list of international locations. We understand that this has potential effects for you and your patients and are including information and guidance below for your convenience.
Athenahealth is providing the latest CDC-recommended guidance for screening and diagnostic testing for 2019 novel coronavirus (2019-nCoV), a rapidly evolving and highly contagious respiratory illness first identified in China and now confirmed in 18 countries including the United States.
2019-nCoV was first identified in December 2019 in the region of Wuhan, Hubei Province, China. To date, 2019-nCoV cases have been reported in 18 countries including the United States. The most recent CDC update on Monday, February 10, 2020, indicated that 12 cases have been confirmed in the United States and dozens more patients across 37 states are currently under investigation with results pending. Confirmed cases are in Wisconsin, Illinois, Washington, California, Massachusetts and Arizona.
The CDC recommends that health care providers obtain a detailed travel history for patients with fever and acute respiratory illness. The management of clinical illness associated with 2019-nCoV is limited to supportive care, as there is no vaccine or specific treatment at this time.
Please review and adhere to CDC recommendations and update screening questionnaires to include CDC questions about potential exposure to 2019-nCoV based on travel, proximity to nCoV patients, and occupational contact. You may also consider creating a 2019-nCoV order set consisting of CDC-recommended diagnostic tests and specimens for collection.
- CDC Situation Summary: https://www.cdc.gov/coronavirus/2019-ncov/index.html
- CDC Interim Guidance for Healthcare Professionals (CDC): https://www.cdc.gov/coronavirus/2019-nCoV/clinical-criteria.html
Thank you for partnering with athenahealth and Quatris Healthco during this public health issue. We’ll continue to monitor this developing situation and will notify you if or when CDC guidance changes. In the meantime, please reach out to our support teams if you have questions at 817-282-0300 or email us at firstname.lastname@example.org